NCT03200587 2024-07-03Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)University of UtahPhase 1 Completed12 enrolled
NCT04551885 2023-09-21FT516 in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated12 enrolled